Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Institut de Recherches Internationales Servier
Femme Max 99 ans
Institut de Recherches Internationales Servier (France)
MAJ Il y a 4 ans
Phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with metastatic breast cancer
Not provided at time of registration and not expected to be available in the future
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier (France)
MAJ Il y a 4 ans
Long term double blind comparison of gliclazide modified release and an oral anti-diabetic given in combination with metformin in type two diabetic patients: a two year international, multicentre, randomised, double-blind, parallel-group study followed by a two year double blind extension
Not provided at time of registration and not expected to be available in the future
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier (France)
MAJ Il y a 4 ans
Evaluation versus placebo of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion of 5 mg of ivabradine, given to patients undergoing a percutaneous coronary intervention following a myocardial infarction with ST segment elevation (STEMI): a pilot, blind, randomised, placebo-controlled, international, multi-centre study including the ancillary sub-study to the clinical study protocol
Not provided at time of registration and not expected to be available in the future
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier (I.R.I.S)
MAJ Il y a 4 ans
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19
To evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier
MAJ Il y a 4 ans
Study assessing two timing of administration of metformin XR, breakfast vs dinner, in type 2 diabetic patients previously treated with the combination metformin-sulfonylurea
Assess efficacy and safety of metformin XR at 2 different daily time of administration - breakfast vs dinner time- in type 2 daibetic patients in combination with sulfonylurea.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier
MAJ Il y a 4 ans
Evaluation of the effects of 4 oral dosages of S 44121 versus placebo on cardiac function and NT-proBNP in patients with chronic heart failure and left ventricular dysfunction. A 12 week, randomized, double-blind, parallel group, placebo controlled, international multicentre study
Evaluation of the effects on cardiac function and NT-proBNP
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
Institut de Recherches Internationales Servier (France)
MAJ Il y a 4 ans
Assessment of the effect of perindopril orodispersible tablet at the dose of 0.150 mg/kg/day on muscular and myocardic functions in the early stage of Duchenne Muscular Dystrophy: a two-year, double-blind, randomised, placebo-controlled study
Not provided at time of registration and not expected to be available in the future
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier (I.R.I.S)
MAJ Il y a 4 ans
Evaluation of administration of gevokizumab versus placebo on the reduction of atheroma plaque inflammation
The primary objective is to evaluate the effect of gevokizumab on arterial wall inflammation reduction following a recent Acute Coronary Syndrome (ACS)
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier (France)
MAJ Il y a 4 ans
Evaluation of the effect of agomelatine and escitalopram on emotions and motivation in healthy male and female volunteers
Not provided at time of registration and not expected to be available in the future
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Institut de Recherches Internationales Servier
MAJ Il y a 4 ans
Effects of ivabradine IV versus placebo on haemodynamic parameters in patients with a low cardiac output syndrome following planned coronary artery bypass surgery and requiring positive inotropic treatment. A phase II, single blind, exploratory, multicentre study
To evaluate the effect of ivabradine administered by intravenous route in Coronary Artery Disease patients presenting a Low Cardiac Output Syndrome following a planned coronary artery bypass graft an...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
1
2
3
4
5
6
7
8
9
10
Suivant